Authors


By Teresa Wilcox, RPh, PhD, Peter Marangos

Latest:

Evidence Generation Is the Foundation to Optimal Product Positioning

Evidence Generation Is the Foundation to Optimal Product Positioning


John Gray, Healthcare Distribution Management Assn.

Latest:

Collaboration key to a healthy supply chain in 2016

HDMA seeks to encourage more outreach to business partners and government


Minna Bak, Helio Health Group

Latest:

First physicians, now patients: Risk avoidance in patient support programs

A look into the growing compliance risks associated with patient services


Michael Casale, HealthBridge

Latest:

Six Essentials for the Next-Generation Sampling Platform

New technological capabilities will enable management of sample-distribution processes to keep up with a challenging environment


Nicola Smith, QuintilesIMS

Latest:

The growing role of clinical trial educators

Addressing patient recruitment and retention issues is a natural role for CTEs


Ed Schoonveld, ZS

Latest:

The Price of Global Health

Defining 'market access'




Gopkiran Rao, Model N Inc.

Latest:

Industry Revenue Management Practices Are Showing Gradual Improvement

The 7th Annual Model N survey shows that industry is struggling with the growing complexity of contracts and pricing for managed care and government programs




Bob Perkins, Vice President, Public Policy

Latest:

AstraZeneca's Principles for Product-Related Online Communications

Industry anticipates meaningful guidance from FDA on use of social media


Elise Whitaker, Orbita

Latest:

AI ‘voice’ grows louder in 2020

Are regulations hindering pharma innovations?



Albert I. Wertheimer, PhD, MBA, Temple University

Latest:

Getting Value From End-of-Life-Cycle Pharmaceuticals

A review of 84 branded pharmaceutical products with changed ownership as of 2005 shows that many of them can continue to sell, often with much higher prices By Albert I. Wertheimer, PhD, MBA, Temple University, and Ellen F. Loh, BS, MBA, University of Maryland, Baltimore


Janice Adkins, Brian Lynch

Latest:

A growing preference for ready-to-administer vaccines: new guidelines, evidence, and trends

Vaccine administration is shifting from multidose vials to prefilled syringes for a host of important safety and economic considerations


Yogesh Bahl, AlixPartners, LLP

Latest:

Managing third-party risks in the life sciences industry

Internal compliance reviews are not enough; life sciences companies need to assess their third-party business partners




Kim Radefeld, Telerx

Latest:

A Big Data approach to patient engagement and adherence

Combining high-quality patient-support services with comprehensive and continually updated analytics results in better outcomes


Dan Haines PhD, Scientific Advisor, SCHOTT Pharma Services

Latest:

Container selection and testing for safe drug product delivery

Elaborate testing is necessary to ensure the stability and functionality of today's drug-delivery systems


Alison Little, Bill Shew

Latest:

Ten integrated imperatives for pharma commercial transformation

The pharma industry needs to go farther in adapting to new marketplace realities


Bernard McGarvey, Eli Lilly

Latest:

A new way to look at the performance of passive cold-chain shipping containers

A 'performance curve' chart for containers could simplify the design process



Walter Berghahn, SmartRmeds for Life

Latest:

Packaging, serialization and medication adherence: the coming connection

Modernized packaging technologies can change the drug-distribution dynamic - and improve overall healthcare


Rod Schregardus, The Access Group

Latest:

Data systems critical to Covid-19 vaccine

With a number of vaccine trials progressing globally, recent data loss and quality control errors have raised the importance of ensuring effective data systems in this effort


By Dyan Bryson, Inspired Health Strategies

Latest:

Emphasize patient interaction in patient support programs

Hubs and other patient services need to stress the personal



Amit Agarwal, Dan Ressler

Latest:

Understanding the companion-diagnostics environment

While the pharma industry is growing more dependent on companion diagnostics, test developers face an uncertain business model


Peggy Wright, Contributing Editor

Latest:

Modified release formulations give new life to drugs

Both pharmacological and economic factors drive the decision to use these technologies

© 2025 MJH Life Sciences

All rights reserved.